Dermatofibromas are small, firm bumps in the skin that are overwhelmingly benign and, for most people, require no treatment at all. They rank among the most common skin growths dermatologists encounter, typically showing up on the legs and arms of adults in their thirties and forties as hard, pea-sized nodules that may be skin-colored, pink, or brownish. Despite being harmless in the vast majority of cases, dermatofibromas can look worryingly like other growths, and the biology behind them turns out to be more interesting than their quiet clinical reputation suggests.
Who Gets Them and Where They Show Up
Dermatofibromas appear more often in women than men. A clinicopathological analysis of 239 cases found that about 61% of patients were female, with a mean age around 41 years, and the most common location was the lower extremity, accounting for roughly half of all cases, followed by the upper extremity at about 35%.1PubMed Central. Dermatofibroma: clinicopathological analysis of 239 cases A separate retrospective review of 200 lesions confirmed similar demographics: a female-to-male ratio of roughly 2 to 1, a mean age in the low forties, and a preference for the legs.2PubMed. Clinical, histopathological, dermatoscopic and digital microscopic features of dermatofibroma: a retrospective analysis of 200 lesions The reason for this predilection for the lower limbs in adults is not fully understood, though the legs are a common site for minor injuries and insect bites, which have long been considered possible triggers.
Most people develop a single dermatofibroma, or a handful over a lifetime. They tend to persist indefinitely once they form. You might notice one after shaving your legs or discover it as a firm lump you had not paid attention to before. They are rarely painful, though some can be mildly tender when pressed or bumped.
The Dimple Sign
The classic clinical test for a dermatofibroma is the “dimple sign,” sometimes called Fitzpatrick’s sign. If you squeeze the skin on either side of a suspected dermatofibroma, the center dimples inward rather than popping outward, because the lesion is tethered to the overlying skin. Dermatofibromas are pigmented papules or nodules that produce this dimple sign when laterally squeezed and are usually found on the legs, and these features alone lead to the diagnosis in most cases.3PubMed Central. Multiple dermatofibromas: dermoscopic patterns The sign is considered indicative of a benign lesion.4PubMed. Cutaneous signs of systemic disease
However, the dimple sign is not quite the foolproof identifier textbooks sometimes imply. Not all dermatofibromas dimple, and not every lesion that dimples is a dermatofibroma.5PubMed. ‘Dimpling’ is not unique to dermatofibromas Other fibrotic or tethered skin growths can produce a similar effect. So while the sign is useful, clinicians generally combine it with other features before settling on a diagnosis.
What They Actually Are
For decades, dermatologists debated whether dermatofibromas were truly growths or simply a scar-like reaction to some past injury, like an insect bite or a minor wound. The reactive-process theory made intuitive sense: many patients recall a prior injury at the site, and under the microscope the lesion looks like an exuberant healing response with spindle-shaped cells, collagen, and inflammatory infiltrate.
That debate has shifted decisively. Molecular studies have found that dermatofibromas harbor recurrent gene fusions involving protein kinase C isoforms and genes encoding membrane-associated proteins. These fusions are predicted to create abnormal proteins with constitutive enzyme activity, meaning the cells are driven to proliferate in a way characteristic of a true tumor, not just a reaction.6PubMed. Fusions involving protein kinase C and membrane-associated proteins in benign fibrous histiocytoma Subsequent work has expanded the list of fusion partners and confirmed the finding across different subtypes, reinforcing that dermatofibromas are clonal neoplasms, not reactive lesions.7The American Journal of Dermatopathology. Cellular Dermatofibroma Harboring a Novel MYADM::PRKCG Gene Fusion: A Case Report This distinction matters less for the individual patient, since the tumors are still benign, but it has reshaped how pathologists classify and study them.
Dermoscopic Patterns and Diagnosis
When a dermatologist looks at a dermatofibroma through a dermatoscope, the most common pattern is a white scar-like patch in the center surrounded by a delicate light-brown pigment network at the periphery. In a prospective study of 412 dermatofibromas, a pigment network was present in about 72% and a central white scar-like patch in about 57%, with the classic combined pattern seen in roughly 35% of cases.8JAMA Dermatology. Dermoscopy of Dermatofibromas: A Prospective Morphological Study of 412 Cases That means the majority of dermatofibromas actually present with patterns other than the “textbook” appearance, including some that can mimic melanoma. An earlier smaller study found the central white patch in over 90% of cases, though the sample was much smaller at 24 lesions.9Journal of the American Academy of Dermatology. Central white scarlike patch: A dermatoscopic clue for the diagnosis of dermatofibroma
The fact that roughly two-thirds of dermatofibromas do not show the most frequently described pattern is worth knowing. It means a dermatoscope alone cannot always clinch the diagnosis. For atypical-looking lesions, a biopsy settles things. Under the microscope, dermatofibromas show a characteristic proliferation of spindle-shaped cells in the dermis with overlying epidermal thickening and entrapment of collagen at the edges.
Histological Variants
Not all dermatofibromas look the same under the microscope, and some variants are more clinically relevant than others. A histopathological review of cases found the common fibrous histiocytoma type accounted for about 80% of lesions, with the remaining 20% split among several variants including aneurysmal, hemosiderotic, epithelioid, cellular, lipidized, atrophic, and clear cell types.10PubMed Central. Variants of dermatofibroma–a histopathological study
The cellular variant deserves special mention because it behaves differently from the common type. A review of 218 cellular dermatofibromas found that initial lesion size greater than 1 cm seemed to be associated with a greater likelihood of recurrence, and when surgical margins were involved on the initial biopsy, there was a roughly 10% chance of the lesion coming back.11PubMed. Cellular Dermatofibroma: Clinicopathologic Review of 218 Cases of Cellular Dermatofibroma to Determine the Clinical Recurrence Rate A separate retrospective series of cellular dermatofibromas reported a recurrence rate of about 33%, with some patients experiencing three or more recurrences.12PubMed. A retrospective review of 93 cases of cellular dermatofibromas The wide gap between those two figures likely reflects differences in how completely the lesions were removed in each series. Either way, cellular dermatofibromas recur far more often than the common type, which essentially never comes back.
The aneurysmal variant can also catch patients off guard. These lesions contain blood-filled spaces that can make them appear suddenly larger or bruised. A large clinicopathologic study of 168 aneurysmal and 29 hemosiderotic dermatofibromas found that both variants tended to be larger than typical dermatofibromas and had a lower female predominance. Aneurysmal dermatofibromas favored exposed areas like the face and forearm, while hemosiderotic variants clustered on the lower leg, where nearly all of the lower-leg cases showed signs of venous stasis.13PubMed. 168 Cases of aneurysmal dermatofibroma and 29 cases of hemosiderotic dermatofibroma: A clinicopathologic study
The atypical variant is perhaps the most diagnostically treacherous. It features scattered pleomorphic (oddly shaped) cells and can show mitotic activity that mimics a sarcoma. Low-magnification attention to the overall architecture of the lesion is important to avoid misdiagnosis as a malignant tumor.14Modern Pathology. Cutaneous soft tissue tumors: how do we make sense of fibrous and “fibrohistiocytic” tumors with confusing names and similar appearances?
Telling a Dermatofibroma from Something Dangerous
The growth that clinicians most need to distinguish from a dermatofibroma is dermatofibrosarcoma protuberans (DFSP), a slow-growing but locally aggressive skin cancer. Both can present as firm, flesh-colored bumps, and in some cases their microscopic features overlap enough to cause genuine diagnostic difficulty.
Pathologists have traditionally relied on immunohistochemical staining to separate the two. CD34 is frequently strongly positive in DFSP but negative in most dermatofibromas, while Factor XIIIa shows the opposite pattern, being positive in the vast majority of dermatofibromas and infrequent in DFSP.15PubMed. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa A scoping review of immunohistochemical profiles across multiple studies found CD34 and Factor XIIIa were the most commonly used markers, with CD34 strongly positive in about 96% of DFSPs versus only about 16% of dermatofibromas.16medRxiv. Immunohistochemical profiles of dermatofibroma and dermatofibrosarcoma protuberans: A scoping review Some overlap exists, though, so newer markers are being explored. The same review noted that markers like WT1, connexin 43, and LSP-1 showed the greatest difference in expression between the two tumors.
Beyond staining, the cells themselves look different. A nuclear morphology study found that an alternating ovoid-spindled nuclear shape was predominant in 98% of DFSP cases and was not predominant in any dermatofibroma cases, making it a highly specific and sensitive feature for identifying DFSP.17PubMed Central. Dermatofibroma vs. Dermatofibrosarcoma Protuberans: A Nuclear Morphology Study
Imaging is also emerging as a tool to separate these lesions before biopsy. A 15-year retrospective analysis using high-frequency and ultra-high-frequency ultrasound found that tumor location, size, and specific ultrasound patterns (such as tentacle-like borders and mixed echogenicity favoring DFSP) could serve as independent predictors to distinguish the two.18PubMed Central. Diagnostic Performance of High-Frequency Ultrasound and Ultra-High-Frequency Ultrasound in Distinguishing Dermatofibrosarcoma Protuberans from Dermatofibroma: A 15-year Period Retrospective Analysis Very-high-frequency ultrasound has also been studied for characterizing dermatofibromas specifically: typical features include a lesion under 10 mm, ill-defined borders within the dermis, a thickened junction between the skin layers, and minimal blood flow on Doppler imaging.19PubMed Central. Evaluation of Very-High-Frequency Ultrasound Imaging Characteristics of Dermatofibroma
When Multiple Dermatofibromas Appear at Once
A single dermatofibroma is unremarkable. A sudden eruption of many, however, can be a signal worth investigating. This pattern, called multiple eruptive dermatofibroma, is usually associated with immune disorders. The most frequently reported associations are systemic lupus erythematosus and HIV infection, along with hematologic cancers and immunosuppressive drug therapy.20PubMed Central. Multiple Eruptive Dermatofibroma: A Case Report
A systematic review quantified these associations: immunosuppressive drugs accounted for about 23% of cases, systemic lupus erythematosus for roughly 20%, HIV for about 10%, and hematologic malignancy for about 9%.21PubMed. Multiple dermatofibromas, associated clinical and histological characteristics: A systematic review Having multiple dermatofibromas that cluster together in a healthy person with normal immune function is a different entity from the eruptive pattern and does not carry the same clinical concern. The key distinction is the “eruptive” part: many lesions developing over a short period, rather than a handful accumulating over years.
Treatment and When to Consider It
Most dermatofibromas do not need treatment. They are benign, stable, and, aside from occasional tenderness, symptom-free. The main reasons people seek treatment are cosmetic concerns, irritation from clothing or shaving, or uncertainty about whether the bump might be something else.
Surgical excision is the standard approach when removal is desired. Because dermatofibromas extend into the dermis, shave removal often leaves behind deeper tissue and can result in recurrence. Full excision with adequate margins avoids this but leaves a scar, which on the legs can be more conspicuous than the original lesion. For the common type, recurrence after complete excision is rare. For the cellular variant, as discussed earlier, recurrence rates are substantially higher.
Pulsed dye laser has been studied as a less invasive alternative. A trial using a 600 nm pulsed dye laser on 20 dermatofibromas found that 75% showed complete response in terms of size reduction, and 60% showed complete improvement in color. All six lesions that were symptomatic (tender or irritating) had complete resolution of symptoms after treatment.22PubMed. Treatment of dermatofibroma with a 600 nm pulsed dye laser Laser treatment may offer a better cosmetic outcome than surgery, particularly for lesions on visible areas, though larger studies would strengthen the evidence.
Cryotherapy (freezing) is sometimes used but tends to flatten the lesion rather than eliminate it, and results are variable. For most patients, the honest conversation is whether the scar from removal will bother you more than the original bump.
Dermatofibromas in Children
Dermatofibromas are uncommon in children and rare before age five. A review from a single institution identified 267 patients under 18 with dermatofibromas or the closely related dermatomyofibroma, and only about 5% occurred in children younger than five.23PubMed. Fibrous histiocytoma/dermatofibroma in children: the same as adults?
When they do occur in children, the location pattern differs from adults. While adults overwhelmingly get dermatofibromas on their legs, a pediatric study of 53 cases found the back and chest were the most common sites at 38%, followed by the legs at 28% and the arms at 23%. Interestingly, the most common pre-biopsy guess by clinicians was “cyst” (43%), not dermatofibroma (30%), which highlights that these lesions are not on the diagnostic radar for many physicians when they see them in younger patients.24PubMed. Pediatric dermatofibromas: Truncal predominance in younger children The truncal predominance in children is a consistent finding that distinguishes the pediatric presentation from the adult one, though the reason remains unclear.
The Extremely Rare Worst-Case Scenario
Dermatofibromas are classified as benign, and for practical purposes they are. But a handful of case reports in the medical literature describe dermatofibromas that metastasized, almost always to the lungs. One such report documented a lung mass that, on microscopic examination, showed the same cell types and staining pattern as the patient’s skin lesion.25Annals of Diagnostic Pathology. Metastasizing dermatofibroma in lung These cases are extraordinarily rare and tend to be associated with the cellular or atypical variants rather than the common type. They are worth mentioning not because they should cause alarm but because they explain why pathologists take care to classify the specific variant when a dermatofibroma is biopsied. A garden-variety dermatofibroma has essentially zero risk of spreading; a cellular variant with positive margins warrants closer follow-up.
Some recently described tumors that were originally classified as atypical dermatofibromas have turned out, on molecular testing, to be different entities entirely. A study examining superficial tumors that mimicked atypical dermatofibromas found that 60% of the reclassified cases carried a PRDM10 rearrangement, placing them in a separate tumor category.26PubMed. Clinicopathologic and molecular study of superficial CD34-positive fibroblastic tumours mimicking atypical fibrous histiocytoma (dermatofibroma) Molecular diagnostics are gradually sharpening the line between true dermatofibromas and look-alikes, which should improve both diagnosis and prognosis for patients whose lesions fall in the gray zone.